



VALIDATION, IMPLEMENTATION AND ROUTINE WORK WITH TOTAL LAB-AUTOMATION BD-KIESTRA :  
A TWO-YEAR EXPERIENCE AT THE UNIVERSITY HOSPITAL OF LIÈGE, BELGIUM 
INTRODUCTION 
1. A part of the process to qualify the BD-K TLA recently installed 
in our laboratory was to design a validation plan including 
scope, goals of the different steps, time-lines and acceptance 
criteria. Here, only a part of the validation plan is presented: i.e. 
all the parameters that had to be checked before BD-K TLA 
implementation, established by the Key User Group BD-Kiestra 
of the laboratory, University Hospital of Liège.  
2. To evaluate the added-value of this full-automated system 
compared to manual bacteriology. 
Automation in Bacteriology is a major revolution in clinical 
microbiology laboratories. At the University Hospital of Liège 
(Belgium), a BD-Kiestra Total Laboratory Automation (BD-K-TLA) 
system has been installed in September 2015, and started in 
routine (“Go-live”) in November 2015. Here, we describe the 
validation process achieved for the implementation of the BD-K-
TLA system, and some aspects of our two-year experience in the 
daily practice in the laboratory. 
 Between 2015 and 2018, the number of specimens for bacterial cultures processed each 
February, as well as the annual number of processed specimens, have increased (+14,0% and 12.0% 
respectively).  Despite bacteriological full automation with the BD-K TLA, it was not possible to process 
the increasing amount of work with constant staff: the lab technician team was enlarged of 1.5 FTE 
(+11,5%).  
 To observe major time saving with BD-K TLA, in order to dedicate lab technician 
resources, as initially expected, to more added-value tasks, a well-considered configuration 
of the system, a major reorganization of the workflow and optimal technical performances 
(hardware and software) of the BD-K TLA are mandatory.  
The optimization of the incubation times before reading, reading on screen at any time when 
pictures are ready, as well as improved isolation of colonies obtained with the “bead spreading” 
should theoretically decreased the TTPR. Our data have showed a stable positivity rate but have 
not impact the TTPR. To observe the expected theoretical improvement, working 24h/24 would 
possibly do better ; with a 8 am to 6 pm schedule, it is difficult to observe a significant shorter TTPR. 
A 24/7 schedule, with continuous reading and follow-up, should be implemented in order to 
observe a major reduction of the general time to result (for both positive and negative samples). 
 BD-K TLA provides traceability through the whole process, quality of inoculation, defined 
incubation times and better biological validation by clinical microbiologists, thanks to 
remote pictures review.  
DISCUSSION - CONCLUSION 
Aiming to set up a Key-user group, inventory of competences and 
willing of the different staff members to be involved in the validation 
process and further management of the BD-K TLA has been 
established . 
For the objective 2, we measured 3 parameters for 4 similar 
periods, before (February 2015) and after (February 2016, 2017, 
2018) implementation of the BD-K TLA : (1) the number of lab 
technician resources (expressed in FTE) (2) the positivity rate (%), 
defined as the number of significant positive cultures among the 
total of samples analyzed and (3) the time to positive result (TTPR), 
defined as the time (in hours) between reception of a specimen in 
the Microbiology laboratory and the isolation of a significant 
pathogen in this sample. All specimens were included, except 
respiratory samples and blood cultures. During the different periods 
(pre- and post- BD-K TLA implementation), opening hours of the 
laboratory remained unchanged : from 8 am to 6 pm. 
2. COMPARISON BETWEEN PRE- AND POST-IMPLEMENTATION OF 













Comparison of 3 periods of routine work processed with BD-K TLA (Feb. 2016, 2017 and 2018) and   
February 2015 when routine work was still processed with conventional manual bacteriology (Tables 1 & 2): 
 Through the different periods, the number of processed specimens has increased: February 2018 
compared with February 2015 showed an increase of 14,0% of the number of samples ;  and globally, 
the number of processed specimens in 2017 was 12.0 % higher than in 2015 (see Table 3). 
 In parallel, lab technicians resources has also increased: between Feb.2016 and Feb.2017, to 
process all the specimens, it was necessary to hire 1,5 additional FTE lab technician (+11,5%).  
 The number of significant positive cultures has remained stable, with a mean positivity rate of 19,3%. 
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(+11.5%) 
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Figure 1. Summarizing schema of the validation plan 
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• Traceability: input/output of plates 
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• CO2  level 
•Imaging settings (Optis®) 
• Lighting 
•Timing 
• Validation of settings 
between the different RC 
• Contamination 
•  Cleaning procedure 
• External incubations 
• Flow and management of 




• Stress test 
•Traceability: input/output of 
plates 
BarcodA 
•Traceability of plates 
•Type of commercial dishes 
supported on the TLA 
• Position of plates in the 
different boxes 
DBManager 
• Configuration and 
validation of the different 
Analysis sets and LIMS 
transmission 
InoqulA 
• Test different container types 
• Caps opening/closing 
• Readability of barcode labels 
• Liquids viscositiy 
• Volume of inoculation per sample 
type 
• Choice/validation of spread patterns 
per sample type 
• Inter-sample contamination  
• Repeatability/reproductibility of 
inoculation (FA and SA) 
• Beads cleaning for re-use 
1. VALIDATION PLAN 
During the implementation phase, a Key User Group (KUG) was created to carry on the validation 
process. It was composed of 5 lab technicians, 1 scientific PhD responsible for Quality Insurance in 
Microbiology and 2 clinical microbiologists. The validation plan as processed is schematized in Figure 1. 
Table 1. Compared parameters for 4 similar periods between 
Feb. 2015 and Feb.2018 in order to evaluate the added-
value of the TLA BD-K compared to manual bacteriology 
  2015 2016 2017 2018 
p-value (2018 
vs 2015) 
Urine 3099 3493 3491 3717         0.05       
Stool 638 504 451 484        < 0.001 
Swabs 420 454 453 430         0.1 
MRSA 
screening 372 344 421 533        < 0.001 
BLSE 
screening 227 216 231 384        < 0.001 
Noble 
specimens 249 208 245 178        < 0.001 
Table 2. Number of samples per specimen- or 
procedure-type cultured in Feb. 2015, 2016, 
2017 and 2018 
2015 2016 2017 2017 vs 2015 
Total number of 
specimens 
74957 79667 83943 + 12.0% 
Table 3. Annual number of specimens (except respiratory samples and 
         blood cultures) processed manually in 2015 and on BD 
       K TLA in 2016-2017 
